Suita, Japan

Hiroshi Koriyama



 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Ibaraki, JP (2005 - 2018)
  • Suita, JP (2016 - 2022)
  • Osaka, JP (2023)

Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hiroshi Koriyama: Innovator in Therapeutic Methods for Skin Diseases

Introduction

Hiroshi Koriyama is a prominent inventor based in Suita, Japan, known for his significant contributions to the field of medical innovations. With a total of eight patents to his name, he has focused on developing preventive and therapeutic methods for inflammatory skin diseases and related conditions.

Latest Patents

Among his latest patents, Koriyama has developed a preventive or therapeutic method for inflammatory skin diseases, such as psoriasis. This method involves administering an oligopeptide as an active ingredient, specifically targeting the DE loop sequence of RANKL protein. Another notable patent addresses the treatment of IL-17A diseases, providing a vaccine that utilizes a polypeptide containing a specific amino acid sequence. This vaccine serves as a prophylactic or therapeutic agent for diseases where IL-17A is an aggravating factor.

Career Highlights

Koriyama has had a distinguished career, working with esteemed institutions such as Osaka University and Anges, Inc. His work has significantly advanced the understanding and treatment of inflammatory skin diseases, showcasing his dedication to medical research and innovation.

Collaborations

Throughout his career, Koriyama has collaborated with notable colleagues, including Hironori Nakagami and Ryuichi Morishita. These partnerships have further enriched his research and contributed to the development of effective therapeutic methods.

Conclusion

Hiroshi Koriyama's innovative work in the field of therapeutic methods for skin diseases highlights his role as a leading inventor. His contributions continue to impact the medical community and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…